Abesamis, Alex Hagaiza C.

HRN: 19-50-31  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/23/2025
CEFUROXIME 750MG (VIAL)
06/23/2025
06/29/2025
IV
570mg
Q8h
T/c Urinary Tract Infection
Checking Initial Appropriateness 
06/26/2025
CEFTRIAXONE 1G (VIAL)
06/26/2025
07/03/2025
IV
750mg
Q12
Persistent Fever
Checking Initial Appropriateness 
06/26/2025
SODIUM FUSIDATE 20MG/G, 15G OINTMENT
06/26/2025
07/03/2025
TOPICAL
Pea-size
BID
Phlebitis
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: